Literature DB >> 12493646

Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome.

James Orme1, Joshua S Romney, Ramona O Hopkins, Donna Pope, Karen J Chan, George Thomsen, Robert O Crapo, Lindell K Weaver.   

Abstract

Although survival rates for acute respiratory distress syndrome have increased, there is only limited information regarding the quality of life and the relationship between quality of life and pulmonary function after survival. We prospectively measured pulmonary function, emotional function, and health-related quality of life in a cohort of acute respiratory distress syndrome survivors recruited from patients who were enrolled in a randomized clinical trial of high versus low tidal volume mechanical ventilation at 1 year after their recovery. No significant differences were found between the patients treated with high and low tidal volumes on any pulmonary function measure. Approximately 80% of the patients in both groups demonstrated reduced diffusing capacity; 20% had airflow obstruction, and 20% had chest restriction. Scores on measures of depression and anxiety were within the normal ranges, suggesting that they did not have significant affective symptoms. However, both groups reported decreased health-related quality of life in physical functioning, physical ability to maintain their roles (role-physical), bodily pain, general health, and vitality (energy) on the Medical Outcome Study Short Form Health Survey with similar physical limitations reported on the Sickness Impact Profile questionnaire. The pulmonary function abnormalities correlated with decreased health-related quality of life for domains reflecting physical function. Acute respiratory distress syndrome survivors treated with high and low tidal volumes have abnormal pulmonary function that was related to decreased health-related quality of life 1 year after hospital discharge.

Entities:  

Mesh:

Year:  2002        PMID: 12493646     DOI: 10.1164/rccm.200206-542OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  68 in total

1.  Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression.

Authors:  Wen-Qin Zhou; Peng Wang; Qiu-Ping Shao; Jian Wang
Journal:  Mol Cell Biochem       Date:  2016-07-08       Impact factor: 3.396

Review 2.  Studying outcomes of intensive care unit survivors: measuring exposures and outcomes.

Authors:  Dale M Needham; David W Dowdy; Pedro A Mendez-Tellez; Margaret S Herridge; Peter J Pronovost
Journal:  Intensive Care Med       Date:  2005-05-21       Impact factor: 17.440

3.  Acute respiratory distress syndrome: a historical perspective.

Authors:  Gordon R Bernard
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

4.  Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury.

Authors:  William J Janssen; Lea Barthel; Alaina Muldrow; Rebecca E Oberley-Deegan; Mark T Kearns; Claudia Jakubzick; Peter M Henson
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 5.  Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.

Authors:  Airan Liu; Xiwen Zhang; Hongli He; Li Zhou; Yoshifumi Naito; Shinji Sugita; Jae-Woo Lee
Journal:  Expert Opin Biol Ther       Date:  2019-11-18       Impact factor: 4.388

6.  Long-Term Pulmonary Function and Quality of Life in Children After Acute Respiratory Distress Syndrome: A Feasibility Investigation.

Authors:  Shan L Ward; Autumn Turpin; Aaron C Spicer; Marsha J Treadwell; Gwynne D Church; Heidi R Flori
Journal:  Pediatr Crit Care Med       Date:  2017-01       Impact factor: 3.624

7.  Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury.

Authors:  G J Rey-Parra; A Vadivel; L Coltan; A Hall; F Eaton; M Schuster; H Loibner; J M Penninger; Z Kassiri; G Y Oudit; B Thébaud
Journal:  J Mol Med (Berl)       Date:  2012-01-14       Impact factor: 4.599

8.  Ventilatory strategies in patients with sepsis and respiratory failure.

Authors:  Dean R Hess; B Taylor Thompson
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

Review 9.  Lung protective ventilation strategy for the acute respiratory distress syndrome.

Authors:  Nicola Petrucci; Carlo De Feo
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 10.  The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.

Authors:  Ellen L Burnham; William J Janssen; David W H Riches; Marc Moss; Gregory P Downey
Journal:  Eur Respir J       Date:  2013-03-21       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.